Treatment of vomiting in breast cancer patients
Phase 3
Completed
- Conditions
- Health Condition 1: null- Breast cancer
- Registration Number
- CTRI/2017/12/010864
- Lead Sponsor
- Mysore medical college ad research institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Female patient with histopathologically
confirmed breast cancer
2. Chemotherapy naïve
3. No nausea/ vomiting in the past 24 hours were
included
Exclusion Criteria
1. Patients with seizure disorder.
2. Brain metastasis.
3. Prior use of antipsychotic agents were excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete response for nausea that is no nausea in the acute, delayed and overall periodsTimepoint: Day 1 to 5 from the start of chemotherapy
- Secondary Outcome Measures
Name Time Method Complete response for vomiting in the acute, delayed and overall periodsTimepoint: Day 1 to 5 from the start of chemotherapy